CLINICAL_TRIALS
trial_result
· 2021-08-17
Clinical Trial Update: Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates on olanzapine for treating chronic nausea and/or vomiting in patients with advanced cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Advanced Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-17